Advaxis, Inc.
(NASDAQ : ADXS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
0.11%46.478.1%$739.31m
AMGNAmgen Inc.
0.35%176.741.3%$505.37m
CELGCelgene Corporation
0.07%91.821.3%$444.49m
GILDGilead Sciences, Inc.
-1.54%67.020.9%$405.12m
BIIBBiogen Inc.
-0.24%233.071.3%$386.76m
ILMNIllumina, Inc.
0.09%302.553.5%$336.07m
REGNRegeneron Pharmaceuticals, Inc.
-0.12%297.832.6%$277.81m
SRPTSarepta Therapeutics, Inc.
-2.46%153.0614.7%$203.75m
ALXNAlexion Pharmaceuticals, Inc.
0.70%123.902.0%$199.53m
VRTXVertex Pharmaceuticals Incorporated
0.32%176.931.9%$188.08m
EXASExact Sciences Corporation
-0.29%115.8524.1%$140.08m
AAgilent Technologies, Inc.
-0.99%69.851.6%$133.92m
INCYIncyte Corporation
-1.36%80.282.5%$114.51m
BLUEBluebird Bio, Inc.
-1.38%133.8814.3%$97.84m
BMRNBioMarin Pharmaceutical Inc.
-1.73%82.544.3%$87.82m

Company Profile

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.